Novo Nordisk | NVO - Receita De Vendas





Vendas Alterar Data
ANI Pharmaceuticals USD 237.5M 9.56M 2026-03
Aurora Cannabis CAD 94.19M 3.82M 2025-12
Bausch Health Companies USD 2.5B 300M 2026-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Canopy Growth CAD 74.54M 7.86M 2025-12
Corcept Therapeutics USD 164.9M 37.22M 2026-03
Drreddys Laboratories INR 87.27B 1.82B 2025-12
Eli Lilly USD 19.8B 500M 2026-03
GlaxoSmithKline GBP 7.63B 991M 2026-03
Merck USD 16.29B 110M 2026-03
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Novartis USD 13.11B 226M 2026-03
Novo Nordisk DKK 96.82B 17.68B 2026-03
Novo Nordisk DKK 12.53B 2.44B 2025-12
Pacira USD 177M 19.87M 2026-03
Perrigo USD 969M 141M 2026-03
Phibro Animal Health USD 373.91M 10.02M 2025-12
Prestige Brands USD 283.44M 9.34M 2025-12
Sanofi EUR 11.24B 60M 2026-03
Supernus Pharmaceuticals USD 207.71M 3.89M 2026-03
Zoetis USD 2.3B 100M 2026-03